{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:04:04Z","timestamp":1789866244908,"version":"4.0.1"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,11,17]]},"DOI":"10.18632\/oncotarget.5334","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T19:50:01Z","timestamp":1445629801000},"page":"38912-38925","source":"Crossref","is-referenced-by-count":46,"title":["Tunicamycin enhances the antitumor activity of trastuzumab on breast cancer\n                    <i>in vitro<\/i>\n                    and\n                    <i>in vivo<\/i>"],"prefix":"10.18632","volume":"6","author":[{"given":"Xiqian","family":"Han","sequence":"first","affiliation":[{"name":"National Glycoengineering Research Center, School of Pharmaceutical Science, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Glycoengineering Research Center, School of Pharmaceutical Science, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[{"name":"National Glycoengineering Research Center, School of Pharmaceutical Science, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengshi","family":"Huang","sequence":"additional","affiliation":[{"name":"National Glycoengineering Research Center, School of Pharmaceutical Science, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Glycoengineering Research Center, School of Pharmaceutical Science, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengshan","family":"Wang","sequence":"additional","affiliation":[{"name":"National Glycoengineering Research Center, School of Pharmaceutical Science, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikang","family":"Shi","sequence":"additional","affiliation":[{"name":"National Glycoengineering Research Center, School of Pharmaceutical Science, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/emboj\/16.7.1647","article-title":"ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling","volume":"16","author":"Hynes","year":"1997","journal-title":"The EMBO Journal"},{"key":"2","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1038\/sj.onc.1210477","article-title":"The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis","volume":"26","author":"Moasser","year":"2007","journal-title":"Oncogene"},{"key":"3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu","volume":"235","author":"McGuire","year":"1987","journal-title":"Science"},{"key":"4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Sliwkowski","year":"2001","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: the complexity of targeted inhibitors","volume":"5","author":"Lane","year":"2005","journal-title":"Nature Reviews Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2174\/13894501113149990161","article-title":"Novel targeted therapies to overcome trastuzumab resistance in HER2-overexpressing metastatic breast cancer","volume":"14","author":"Fan","year":"2013","journal-title":"Current Drug Targets"},{"key":"7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMra043186","article-title":"Trastuzumab-Mechanism of Action and Use in Clinical Practice","volume":"357","author":"Hudis","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"8","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1158\/0008-5472.CAN-08-1056","article-title":"Trastuzumab-Induced HER Reprogramming in \u201cResistant\u201d Breast Carcinoma Cells","volume":"69","author":"Maihle","year":"2009","journal-title":"Cancer Research"},{"key":"9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ccr.2009.03.020","article-title":"Ligand-independent HER2\/HER3\/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941","volume":"15","author":"Sliwkowski","year":"2009","journal-title":"Cancer Cell"},{"key":"10","doi-asserted-by":"crossref","first-page":"19063","DOI":"10.1073\/pnas.0605218103","article-title":"A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions","volume":"103","author":"Blau","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ccr.2007.08.030","article-title":"A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab","volume":"12","author":"van de Vijver","year":"2007","journal-title":"Cancer Cell"},{"key":"12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1406281","article-title":"Adjuvant paclitaxel and trastuzumab for node-negative, HER2- positive breast cancer","volume":"372","author":"Overmoyer","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/tbj.12124","article-title":"Paclitaxel, carboplatin, and trastuzumab in a neo-adjuvant regimen for HER2-positive breast cancer","volume":"19","author":"Linn","year":"2013","journal-title":"Breast Journal"},{"key":"14","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2014.57.1794","article-title":"CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer","volume":"33","author":"Hornyak","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"15","first-page":"857516","article-title":"Endoplasmic reticulum stress: its role in disease and novel prospects for therapy","volume":"2012","author":"Sch\u00f6nthal","year":"2012","journal-title":"Scientifica (Cairo)"},{"key":"16","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/elps.201100565","article-title":"Proteome analysis of tunicamycin-induced ER stress","volume":"33","author":"Thiede","year":"2012","journal-title":"Electrophoresis"},{"key":"17","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1158\/0008-5472.CAN-07-6389","article-title":"Inhibition of N-Linked Glycosylation Disrupts Receptor Tyrosine Kinase Signaling in Tumor Cells","volume":"68","author":"Lawrence","year":"2008","journal-title":"Cancer Research"},{"key":"18","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1158\/1078-0432.CCR-09-3331","article-title":"Molecular Imaging of N-linked Glycosylation Suggests Glycan Biosynthesis Is a Novel Target for Cancer Therapy","volume":"16","author":"Lawrence","year":"2010","journal-title":"Clinical Cancer Research"},{"key":"19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00280-008-0902-8","article-title":"Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib","volume":"64","author":"Haigentz","year":"2009","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"20","first-page":"1941","article-title":"Tunicamycin sensitizes human prostate cells to TRAIL-induced apoptosis by upregulation of TRAIL receptors and downregulation of cIAP2","volume":"40","author":"Kim","year":"2012","journal-title":"International Journal Oncology"},{"key":"21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.canlet.2011.09.034","article-title":"Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells","volume":"314","author":"Sun","year":"2012","journal-title":"Cancer Letters"},{"key":"22","doi-asserted-by":"crossref","first-page":"29127","DOI":"10.1074\/jbc.M110.169771","article-title":"Unfolded Protein Response Is Required in nu\/nu Mice Microvasculature for Treating Breast Tumor with Tunicamycin","volume":"286","author":"Banerjee","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"23","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1158\/0008-5472.CAN-03-3900","article-title":"P27kip1 Down-Regulation Is Associated with Trastuzumab Resistance in Breast Cancer Cells","volume":"64","author":"Esteva","year":"2004","journal-title":"Cancer Research"},{"key":"24","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1158\/0008-5472.CAN-08-0380","article-title":"A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy","volume":"68","author":"Stern","year":"2008","journal-title":"Cancer Research"},{"key":"25","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.1073\/pnas.1537685100","article-title":"The ErbB2\/ErbB3 heterodimer functions as an oncogenic unit: erbB2 requires ErbB3 to drive breast tumor cell proliferation","volume":"100","author":"Hynes","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bcp.2012.09.012","article-title":"Pharmacological targeting of endoplasmic reticulum stress signaling in cancer","volume":"85","author":"Sch\u00f6nthal","year":"2013","journal-title":"Biochemical Pharmacology"},{"key":"27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1751-0813.1993.tb06131.x","article-title":"Experimental tunicamycin toxicity in cattle, sheep and pigs","volume":"70","author":"Carrigan","year":"1993","journal-title":"Australian Veterinary Journal"},{"key":"28","first-page":"1669","article-title":"Biochemical Effects and Therapeutic Potential of Tunicamycin in Murine L1210 Leukemia","volume":"43","author":"Bernacki","year":"1983","journal-title":"Cancer Research"},{"key":"29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1751-0813.1998.tb10162.x","article-title":"Reduction and recovery of N-acetylglucosamine-1-phosphate transferase activity in the liver of sheep","volume":"76","author":"Jago","year":"1998","journal-title":"Australian Veterinary Journal"},{"key":"30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0890-6238(95)02019-5","article-title":"Permanent testicular damage induced in rats by a single dose of tunicamycin","volume":"10","author":"Stewart","year":"1996","journal-title":"Reproductive Toxicology"},{"key":"31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.toxlet.2012.02.017","article-title":"Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model","volume":"211","author":"Zhang","year":"2012","journal-title":"Toxicology Letters"},{"key":"32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2005.11.040","article-title":"Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response","volume":"124","author":"Kaufman","year":"2006","journal-title":"Cell"},{"key":"33","first-page":"102","article-title":"Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation","volume":"4","author":"Zhang","year":"2012","journal-title":"American Journal of Translational Research"},{"key":"34","volume-title":"CalcuSyn-Windows software for dose-effect analysis and synergism\/antagonism quantification, and User's Manual","author":"Lamble","year":"1996"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T13:32:02Z","timestamp":1589376722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":34,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2015,11,17]]}},"alternative-id":["5334","26498681"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5334","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,12]]}}}